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Human T-cell Lymphotropic virus (HTLV) prevalence is
low in the UK, but higher in individuals originating
from endemic countries. Anti-HTLV screening of all
blood donations was introduced in 2002 to reduce the
risk of transfusion transmission. The UK HTLV Cohort
(UHC) was established for longterm follow up of people
affected by HTLV. Recruitment by clinicians at blood
centres and specialist clinics began in July 2003. Partici-
pants are asked to complete a baseline self completion
questionnaire (SCQ) about their health and HTLV risk
factors, flagged in central registries for cancer or death,
and followed up about their health and well being every
2-3 years. Recruiting clinicians report participant’s clinical
state at diagnosis. By March 2013, a total of 161 HTLV
positive individuals had consented to take part: 89 of these
were blood donors. Most were female (77%), of non-white
ethnicity (64%) with a mean age of 49 years. Most (83%)
positive participants were asymptomatic for HTLV at regis-
tration and eight (4%) participants died during follow-up.
Baseline questionnaires were received from 160 (85%).
Follow up was done in 2003, 2007 and 2010, the fourth is
underway. Once complete, approximately 1,000 person
years of follow up will be analyzed, factors associated with
symptoms will be investigated and an assessment of the
progression of HTLV related disease among the UHC will
be presented. Information from the UHC, obtained from a
decade of follow up, will provide a unique perspective
since it is the only cohort of its kind in Europe.
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